pharmaphorum

MAY 24, 2021

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. As the leading creative production partner to brands and agencies, Tag offers a complementary skillset to in-house teams and advertising agencies to bring to life, extend and deploy creative ideas.

Communication 99

Communication Packaging Pharmaceutical Companies Pharmaceutical Companies 99

PharmaShots

MARCH 9, 2023

We are esteemed and elated to present a list of the 20 women who have excelled in reaching the summit of excellence, arranged alphabetically Total experience: 16 yrs. Present company and time period: Pfizer (2 yrs.)

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

The Social Pharmacist

AUGUST 5, 2022

When you first launch your website, you typically don’t possess any rating for your domain authority. Creating excellent content encourages your target audience to read and share. Include some links to your most excellent web-published work. Generally, forums work as an excellent area to advertise your pharmacy website.

HIPAA 52

HIPAA Customer Service Insurance Labelling 52

The Social Pharmacist

AUGUST 5, 2022

When you first launch your website, you typically don’t possess any rating for your domain authority. Creating excellent content encourages your target audience to read and share. Include some links to your most excellent web-published work. Generally, forums work as an excellent area to advertise your pharmacy website.

HIPAA 40

HIPAA Customer Service Insurance Labelling 40

Pharmaceutical Technology

NOVEMBER 30, 2022

In the first quarter since its launch as an approved therapy for type 2 diabetes, Mounjaro has proven to be a lucrative drug, making $97.3 The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3. compared to a 5.1%

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

In the first quarter since its launch as an approved therapy for type 2 diabetes, Mounjaro has proven to be a lucrative drug, making $97.3 The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3. compared to a 5.1%

Insurance 98

Insurance Labelling Communication FDA 98